Albemarle (ALB) Increases Prices of Select ETHACURE Curatives Worldwide
More News related to ALB
- Albemarle (ALB) Sees Pre-Tax Charge of $25-$30M in Q4 Due to Sale of French Facility
- Albemarle Completes the Sale of its Port de Bouc, France Facility to International Chemical Investors Group
- Albemarle Corporation Fourth Quarter 2008 Earnings Conference Call to Be Held January 27,2009 at 10:00am ET
- Albemarle Taking Steps to Respond to Global Economic Volatility - Reduce Costs, Conserve Cash and Reposition for 2009
- Albemarle Names Milan R. Shah Vice President, Business Development
More News related to Corporate News
- Standard & Poor's Lowers Ratings on PNC Financial (PNC)
- DA Davidson Downgrades Cascade (CAE) to Underperform
- BMO Downgrades F5 Networks (FFIV) to Market Perform
- Sterne Agee Downgrades EZCorp (EZPW) to Neutral
- CL King Downgrades Steven Madden (SHOO) to Neutral
Albemarle Corporation (NYSE: ALB) will increase the prices of select ETHACURE curatives worldwide effective September 1, 2008, or as contracts allow. The prices of ETHACURE 100 and ETHACURE 100 LC curatives will increase by $0.35/lb worldwide. The price of ETHACURE 300 curative will increase by $0.30/lb worldwide.
ETHACURE curatives are manufactured in the U.S.A., and are part of Albemarle's Polymer Additives business segment.
Albemarle Corporation (Albemarle) is a global developer, manufacturer and marketer of engineered specialty chemicals.[SM]
Related Categories
Corporate NewsStocks Mentioned
-0.74Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
